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Breast atypias include atypical ductal hyperplasia (ADH), lobular neo-
plasia (LN), flat epithelial atypia (FEA), and apocrine atypia (AA). Diag-
nostic criteria for ADH and LN were established by Page et al, who
noted a 4-5-fold increased risk of breast cancer with long-term follow-
up.1 Similarly, Hartmann et al found 30% of patients with isolated
ADH or LN developed breast cancer (invasive carcinoma or ductal car-
cinoma in situ [DCIS]) at 25-year follow-up.2 Breast cancer risk for iso-
lated FEA and AA is less clear; however, these lesions have been
noted to be associated with ADH and LN. When diagnosed on core
biopsy, ADH is upgraded to cancer on excision in 20-30% of cases,
whereas other atypias are upgraded ≤10% of the time.3 Although data
are emerging that may allow some patients with breast atypias to be
followed clinically,3 many institutions recommend excision, regardless
of atypia type, when diagnosed on core biopsy.
Since breast atypias are risk markers of cancer, but not cancer
themselves, patients may wait longer for next steps in care. This can
lead to patient anxiety and feelings of neglect. We aimed to provide
patients with comprehensible information about their breast atypia
diagnoses in an attempt to ease anxiety.
Patients with first diagnoses of breast atypia on core biopsy (7/
2015-1/2017) were mailed a copy of their pathology report along
with a 1-page information sheet on their diagnosis. The contents of
the information sheets were created by a multi-disciplinary team
(SPR, SH, JCP, KJM, AVN, JMJ) and outlined basic diagnostic criteria,
future risk of cancer, and likely next steps in care (Figure 1). A cover
letter with contact information was also included in case the patient
desired to speak with a breast pathologist (JMJ). Patients were given
a survey at their first clinic visit to assess receipt of mailing, value of
information, and patient comprehension. All patient materials com-
plied with institutional standards for ease in reading, including fonts
(Arial, Lucida), font size (12+ point), and formatting.
Forty patients had first diagnoses of atypia which included 21
(52.5%) ADH, 8 (20%) LN, 6 (15%) FEA, 1 (2.5%) AA, 2 (5%) ADH
and LN, 1 (2.5%) LN and FEA, and 1 (2.5%) ADH and FEA.
Mean time from diagnosis to first appointment was 29 days
(range 6-121). Two (5%) spoke with a pathologist via phone prior to
first appointment. The majority (38/40; 95%) received surveys at
first appointment (one declined an appointment and one was seen
6 days after diagnosis, prior to clinic notification of need for survey).
About 47.4% (18/38) of patients returned surveys. Of the 17
who reported to have received the mailing, the majority (16/17;
88.9%) reported that the information was helpful and understand-
able. Most (14/17; 77.8%) reported that they “did not have breast
cancer”; one patient did not answer this question and wrote “don’t
know” in the margin and 1 patient checked both “I have” and “I do
not have” breast cancer boxes for this question. Of note, 1 patient
reported that the mailing had been received but did not complete
the remainder of the survey.
The majority (38/40; 95%) of patients underwent subsequent
excision with mean time from diagnosis to surgery of 66 days (range
21-140).
Pathology reports provide critical information which guides
patient care. However, they can be detailed and complex, and there-
fore difficult to interpret. In recent years, much attention has been
given to the use of standardized, synoptic pathology reporting to
ensure that important diagnostic and staging elements are present
and readily identifiable by treating clinicians.4,5 These efforts have
been well-received by clinicians.6 Additional efforts have also been
undertaken to help understand and improve clinician comprehension
of pathology reports.7,8 However, many patients are become increas-
ing active in their care, and also desire access to their pathology
reports.
Received: 12 June 2017 | Revised: 15 June 2017 | Accepted: 21 June 2017
DOI: 10.1111/tbj.13061
Breast J. 2018;24:855–857. wileyonlinelibrary.com/journal/tbj © 2018 Wiley Periodicals, Inc. | 855
Pathology reports, even in standardized and synoptic formats,
are not “patient-friendly,” or easily-comprehensible to the typical,
nonmedical professional, patient. Thus, clinicians usually interpret
diagnoses for patients. Many also seek published materials, often on
patient education websites. However, these websites often have a
broad range of information, much of which may not pertain to a
specific diagnosis. Additionally, other online sites may not be credi-
ble and/or may contain misinformation.
We sought to create “patient-friendly” information sheets speci-
fic to breast atypias as patients with these diagnoses represent a
vulnerable population that, because of delays in care (in our study
4 weeks on average from diagnosis to first appointment), may result
F IGURE 1 Example for pathology report and information sheet mailed to patient [Color figure can be viewed at wileyonlinelibrary.com]
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in misinformed patients. In a worse-case scenario, a patient may
believe that they have breast cancer, rather than a risk-associated
lesion.
We had hoped to acquire more patients but found that, even
at a large tertiary breast care center, many had either a prior or
concurrent diagnosis of atypia or carcinoma and were excluded
due to prior counseling/education. Thus, an obvious limitation of
this study is the small size. However, in our small pilot study, all
(16) survey responders reported that the information sheets were
both understandable and helpful, supporting that they were bene-
ficial. Also, 14 of 16 (87.5%) responders noted that they did not
have breast cancer, supporting patient comprehension.
Our findings support that “patient-friendly” supplemental infor-
mation accompanying the pathology report is a beneficial addition
that can help patients transition to next steps in care, especially
when there are anticipated delays. All pathology reports may be able
include “patient-friendly” information to assist with patient compre-
hension of their diagnosis. Notably, multi-disciplinary discussion will
be vital in creating and updating such information to provide consis-
tency in patient education and care.
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